Minimally invasive decompression versus x-stop in lumbar spinal stenosis: a randomized controlled multicenter study

Lumbar spinal stenosis is a prevalent condition among older adults, often leading to neurogenic intermittent claudication. Traditional treatment has centered on laminectomy, but minimally invasive alternatives like X-Stop and minimally invasive decompression (MID) have emerged. While MID is increasingly adopted, X-Stop has shown mixed results compared to nonoperative care. However, data comparing MID and X-Stop directly remain limited. Prior research has shown that both approaches can improve symptoms, but gaps remain in understanding which method offers better long-term outcomes. No prior work had resolved whether one technique reduces the need for reoperation or avoids more severe complications. This uncertainty drove the need for a direct comparison of these two minimally invasive options. Establishing a clearer understanding of their relative benefits could guide clinical decisions for patients with lumbar spinal stenosis.

This study aimed to compare the clinical effectiveness of X-Stop and minimally invasive decompression (MID) in patients with lumbar spinal stenosis and neurogenic intermittent claudication. Researchers sought to determine whether one method provides superior symptom improvement or fewer complications. The specific problem addressed was the lack of direct comparative data between these two minimally invasive techniques. The motivation stemmed from the rising popularity of minimally invasive approaches and the need to inform patient care decisions. Both methods are considered alternatives to traditional laminectomy, but their relative risks and benefits remain unclear. The study focused on a 2-year follow-up period to assess long-term outcomes. The goal was to evaluate not only symptom improvement but also the likelihood of secondary surgery and complication severity. This approach aimed to provide evidence-based guidance for surgical decision-making in this patient population.

The study design was a prospective, randomized controlled multicenter trial involving 96 patients aged 50 to 85 years. Participants had neurogenic intermittent claudication within a 250-meter walking distance and 1- or 2-level lumbar spinal stenosis. Patients were randomly assigned to either minimally invasive decompression (MID) or X-Stop implantation. The primary outcome measure was the Zurich Claudication Questionnaire, analyzed using an intention-to-treat approach. Secondary outcomes included the Oswestry Disability Index, EuroQol 5-dimensional questionnaire, and numerical rating scales for back and leg pain. The study also tracked the risk of secondary surgery and complication rates. Data collection occurred at multiple follow-up intervals over two years. Statistical methods were used to compare outcomes between the two groups, including odds ratios and confidence intervals for secondary surgery rates.

Both groups showed statistically and clinically significant improvements in the Zurich Claudication Questionnaire at six weeks and throughout the two-year follow-up period. No significant differences were observed between the X-Stop and MID groups in symptom improvement at any time point. The primary outcome measure showed similar effectiveness in both treatment arms. However, the X-Stop group had a significantly higher risk of secondary surgery due to persistent or recurrent symptoms. The odds ratio for secondary surgery was 6.5 (95% confidence interval: 1.3–31.9), indicating a sixfold increase in risk for X-Stop compared to MID. Complication rates were low in both groups but more severe in the MID group. These findings suggest that while both methods improve symptoms, X-Stop is associated with a higher likelihood of reoperation. The severity of complications was greater for MID, though overall rates were low.

The authors concluded that both minimally invasive decompression (MID) and X-Stop implantation led to significant symptom improvements in patients with lumbar spinal stenosis. No significant differences were found in clinical outcomes between the two methods at any follow-up time point. However, the X-Stop group had a significantly higher risk of secondary surgery due to persistent or recurrent symptoms. The odds ratio of 6.5 (95% confidence interval: 1.3–31.9) indicates a notable increase in reoperation risk for X-Stop compared to MID. Complication rates were similar and low, but more severe in the MID group. These findings suggest that while both approaches are effective, X-Stop is associated with a higher likelihood of requiring additional surgery. The authors propose that these results may inform clinical decision-making regarding treatment options for lumbar spinal stenosis. The study does not claim that one method is definitively superior to the other in all aspects. The stated implications focus on the relative risks of secondary surgery and complication severity.